JUN and acute promyelocytic leukemia: Significant up regulation was obtained for phosphorylated AP-1 component, c-Jun at serine (63, 73) residue [Fig. 4B], whereas cyclins and cyclin dependent kinases (cdks) expression was down regulated concentration - dependently in APL cells treated with cisplatin [Fig. 4A].